In addition to the termination of the contract, the agency is imposing “intermediate sanctions” to suspend all enrollment and marketing activities for the plan, effective Jan. 12.
The sanctions “will remain in effect until CMS is satisfied that the deficiencies that are the basis for the sanction determination have been corrected and are not likely to recur,” CMS wrote.
Zing Health does have the opportunity to appeal.
Zing was founded by Health2047, a venture fund founded by the American Medical Association. The plan has been in operation since January 2020. It received a 2.5-star rating in 2022, 2023 and 2024.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
